Receive conference highlights, journal articles, and online medical education activities straight to your inbox.
Trending Topic
Endocrine therapy (ET) has changed the natural history of hormone receptor-positive (HR+) breast cancer (BC) and is the cornerstone of the treatment of HR+ BC. There are several ETs approved for the treatment of BC, including selective oestrogen receptor modulators (SERMs; tamoxifen), aromatase inhibitors (AIs; anastrazole, letrozole and exemestane)Â and selective oestrogen receptor degraders (SERDs; fulvestrant […]
This content has been developed independently by Touch Medical Media for touchONCOLOGY in conjunction with expert faculty. This content is not affiliated with ESGO 2024.
This content has been developed independently by Touch Medical Media for touchONCOLOGY. It is not affiliated with the American Society of Clinical Oncology (ASCO).
View highlights and coverage from leading international Oncology congresses
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.